StockData
Waters Corp logo

Waters Corp

WATNYSELaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Nov 10, 2026Score 9/30441% above fair value
$440.45−16.03 (-3.51%)

Close on Nov 20, 2026Market cap $43.27BP/E 109.8Yield –

Waters Waters Biosciences Division Revenue by Quarter

Waters Biosciences Division (WBD) Revenue (Comparable Basis) ($M)

Waters Waters Biosciences Division Revenue: $396M in Q3 2026, up 2.3% from a year earlier.

Latest, Q3 2026
396
Period ended Sep 30, 2026
Change on a year earlier
+2.3%
387 in Q3 2025
History
6 quarters
Since Q1 2025
Sources
6
Documents cited below

Where the Q3 2026 figure comes from

“Biosciences Division (WBD) 396 — * *”

Source: Q3 2026 Form 8-K (Item 2.02 Earnings Release) ↗

Flow cytometry instruments (FACSLyric, FACSDiscover), clinical cell analysis, and fluorochrome/antibody reagents acquired from BD in February 2026.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedWaters Biosciences Division (WBD) Revenue (Comparable Basis) ($M)Year on yearSource
Q3 2026Sep 30, 2026396+2.3%Q3 2026 Form 8-K (Item 2.02 Earnings Release) ↗
Q2 2026Jun 30, 2026368+2.8%Q2 2026 Form 8-K (Item 2.02 Earnings Release) ↗
Q1 2026Mar 31, 2026232+6.9%Q1 2026 Form 8-K (Item 2.02 Earnings Release) ↗
Q3 2025Sep 30, 2025387–Q3 2026 Earnings Presentation (2026-11-03), Slide 28 ↗
Q2 2025Jun 30, 2025358–Q2 2026 Earnings Presentation (2026-08-04), Slide 30 ↗
Q1 2025Mar 31, 2025217–Q1 2026 Earnings Presentation (2026-05-05), Slides 18 & 25-27 ↗

Breakdown

What makes up waters Biosciences Division Revenue

Cite this data

StockData. (2026). Waters Waters Biosciences Division Revenue ($M), quarterly Q1 2025–Q3 2026 [Data set]. Compiled from Waters SEC filings and investor materials. https://stockdatahq.com/stocks/wat/kpis/wbd-total-comp

See every metric in the Waters KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?